Skip to main navigation Skip to search Skip to main content

Cost avoidance analysis of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation for patients enrolled in value-based payment models at an academic hospital

Research output: Contribution to journalArticlepeer-review

Abstract

We previously characterized a reduction in unscheduled care following implementation of ID pharmacist review of outpatient parenteral antimicrobial therapy plans for patients discharging from acute care. In this report we demonstrate the cost avoidance that this intervention would be expected to generate for patients enrolled in value-based-care plans.

Original languageEnglish (US)
Article numbere86
JournalAntimicrobial Stewardship and Healthcare Epidemiology
Volume6
Issue number1
DOIs
StatePublished - Apr 1 2026

Bibliographical note

Publisher Copyright:
© The Author(s), 2026. Published by Cambridge University Press.

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Cost avoidance analysis of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation for patients enrolled in value-based payment models at an academic hospital'. Together they form a unique fingerprint.

Cite this